Download PDF
Semin Respir Crit Care Med 2010; 31(6): 649-673
DOI: 10.1055/s-0030-1269826
© Thieme Medical Publishers

The Pleura in Health and Disease

Rajmohan Murali1 , Kevin Park2 , Kevin O. Leslie3
  • 1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York
  • 2Good Samaritan Hospital, Phoenix, Arizona
  • 3Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona
Further Information

Publication History

Publication Date:
06 January 2011 (online)

    Permissions and Reprints

ABSTRACT

A wide variety of local, regional, and systemic diseases may have pleural manifestations. The scope of this pathology encompasses a wide spectrum ranging from minimal inflammatory changes to highly malignant neoplasms. An overview of the normal structure of the pleura is provided, along with the diseases that may be encountered. Pleural specimens from patients with pneumothorax are rarely encountered by pathologists. In contrast, pathologists frequently receive pleural specimens showing evidence of inflammation, repair, or neoplasm. In these circumstances, an awareness of less common (and often clinically highly important) conditions such as epithelioid hemangioendothelioma and primary pleural malignant mesothelioma is essential. Knowledge of the clinical setting (e.g., disease tempo) and radiological picture (e.g., laterality) is often of great value to the pathologist in arriving at a correct diagnosis. Similarly, knowledge of the normal anatomical considerations and familiarity with the expected pleural histopathology for the most clinically relevant pleural diseases are critical assets for pulmonary physicians in providing optimal care for their patients.

KEYWORDS

Pleura - pathology - disease - infection - neoplasms - mesothelioma

REFERENCES

  • 1 Davies J. Development of the respiratory system. In: Davies J, ed. Human Developmental Anatomy. New York: Ronald Press; 1963: 135-143
    Google Scholar
  • 2 Wang N S. Anatomy of the pleura.  Clin Chest Med. 1998;  19 229-240
    CrossrefPubMedGoogle Scholar
  • 3 Sahn S A. State of the art: the pleura.  Am Rev Respir Dis. 1988;  138 184-234
    CrossrefPubMedGoogle Scholar
  • 4 Wang N S. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura.  Am Rev Respir Dis. 1975;  111 12-20
    PubMedGoogle Scholar
  • 5 Ahmad Z, Krishnadas R, Froeschle P. Pleural effusion: diagnosis and management.  J Perioper Pract. 2009;  19 242-247
    PubMedGoogle Scholar
  • 6 Jantz M A, Antony V B. Pathophysiology of the pleura.  Respiration. 2008;  75 121-133
    CrossrefPubMedGoogle Scholar
  • 7 Rahman N M, Chapman S J, Davies R J. The approach to the patient with a parapneumonic effusion.  Clin Chest Med. 2006;  27 253-266
    CrossrefPubMedGoogle Scholar
  • 8 Sahn S A. Pleural effusions of extravascular origin.  Clin Chest Med. 2006;  27 285-308
    CrossrefPubMedGoogle Scholar
  • 9 Gaudio E, Rendina E A, Pannarale L, Ricci C, Marinozzi G. Surface morphology of the human pleura. A scanning electron microscopic study.  Chest. 1988;  93 149-153
    CrossrefPubMedGoogle Scholar
  • 10 Tarn A C, Lapworth R. Biochemical analysis of pleural fluid: what should we measure?.  Ann Clin Biochem. 2001;  38(Pt 4) 311-322
    CrossrefPubMedGoogle Scholar
  • 11 Light R W, Macgregor M I, Luchsinger P C, Ball Jr W C. Pleural effusions: the diagnostic separation of transudates and exudates.  Ann Intern Med. 1972;  77 507-513
    CrossrefPubMedGoogle Scholar
  • 12 Pereira T C, Saad R S, Liu Y, Silverman J F. The diagnosis of malignancy in effusion cytology: a pattern recognition approach.  Adv Anat Pathol. 2006;  13 174-184
    CrossrefPubMedGoogle Scholar
  • 13 Bedrossian C W. Diagnostic problems in serous effusions.  Diagn Cytopathol. 1998;  19 131-137
    CrossrefPubMedGoogle Scholar
  • 14 Fetsch P A, Abati A. Immunocytochemistry in effusion cytology: a contemporary review.  Cancer. 2001;  93 293-308
    CrossrefPubMedGoogle Scholar
  • 15 Das D K. Serous effusions in malignant lymphomas: a review.  Diagn Cytopathol. 2006;  34 335-347
    CrossrefPubMedGoogle Scholar
  • 16 Reis-Filho J S, de Landér Schmitt F C. Fluorescence in situ hybridization, comparative genomic hybridization, and other molecular biology techniques in the analysis of effusions.  Diagn Cytopathol. 2005;  33 294-299
    CrossrefPubMedGoogle Scholar
  • 17 Roggli V L. Role of closed-needle biopsy in the diagnosis of malignant mesothelioma of the pleura.  Chest. 1994;  105 321-322
    PubMedGoogle Scholar
  • 18 Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients, I: Diagnosis.  Cancer. 1993;  72 389-393
    CrossrefPubMedGoogle Scholar
  • 19 Srinivas S, Varadhachary G. Spontaneous pneumothorax in malignancy: a case report and review of the literature.  Ann Oncol. 2000;  11 887-889
    CrossrefPubMedGoogle Scholar
  • 20 Kelly A M. Treatment of primary spontaneous pneumothorax.  Curr Opin Pulm Med. 2009;  15 376-379
    CrossrefPubMedGoogle Scholar
  • 21 Kurihara M, Kataoka H, Ishikawa A, Endo R. Latest treatments for spontaneous pneumothorax.  Gen Thorac Cardiovasc Surg. 2010;  58 113-119
    CrossrefPubMedGoogle Scholar
  • 22 Noppen M, De Keukeleire T. Pneumothorax.  Respiration. 2008;  76 121-127
    CrossrefPubMedGoogle Scholar
  • 23 Melton III L J, Hepper N G, Offord K P. Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974.  Am Rev Respir Dis. 1979;  120 1379-1382
    PubMedGoogle Scholar
  • 24 Bense L, Wiman L G, Hedenstierna G. Onset of symptoms in spontaneous pneumothorax: correlations to physical activity.  Eur J Respir Dis. 1987;  71 181-186
    PubMedGoogle Scholar
  • 25 Jordan K G, Kwong J S, Flint J, Müller N L. Surgically treated pneumothorax. Radiologic and pathologic findings.  Chest. 1997;  111 280-285
    CrossrefPubMedGoogle Scholar
  • 26 Bense L, Eklund G, Wiman L G. Smoking and the increased risk of contracting spontaneous pneumothorax.  Chest. 1987;  92 1009-1012
    CrossrefPubMedGoogle Scholar
  • 27 Bense L. Spontaneous pneumothorax.  Chest. 1992;  101 891-892
    CrossrefPubMedGoogle Scholar
  • 28 Askin F B, McCann B G, Kuhn C. Reactive eosinophilic pleuritis: a lesion to be distinguished from pulmonary eosinophilic granuloma.  Arch Pathol Lab Med. 1977;  101 187-191
    PubMedGoogle Scholar
  • 29 Shilo K, Colby T V, Travis W D, Franks T J. Exuberant type 2 pneumocyte hyperplasia associated with spontaneous pneumothorax: secondary reactive change mimicking adenocarcinoma.  Mod Pathol. 2007;  20 352-356
    CrossrefPubMedGoogle Scholar
  • 30 Shields T W, Oilschlager G A. Spontaneous pneumothorax in patients 40 years of age and older.  Ann Thorac Surg. 1966;  2 377-383
    CrossrefPubMedGoogle Scholar
  • 31 Dines D E, Clagett O T, Payne W S. Spontaneous pneumothorax in emphysema.  Mayo Clin Proc. 1970;  45 481-487
    PubMedGoogle Scholar
  • 32 George R B, Herbert S J, Shames J M, Ellithorpe D B, Weill H, Ziskind M M. Pneumothorax complicating pulmonary emphysema.  JAMA. 1975;  234 389-393
    CrossrefPubMedGoogle Scholar
  • 33 Newsome G S, Ward D J, Pierce P F. Spontaneous pneumothorax in patients with acquired immunodeficiency syndrome treated with prophylactic aerosolized pentamidine.  Arch Intern Med. 1990;  150 2167-2168
    CrossrefPubMedGoogle Scholar
  • 34 Gerein A N, Brumwell M L, Lawson L M, Chan N H, Montaner J S. Surgical management of pneumothorax in patients with acquired immunodeficiency syndrome.  Arch Surg. 1991;  126 1272-1276, discussion 1276–1277
    PubMedGoogle Scholar
  • 35 Wilder R J, Beacham E G, Ravitch M M. Spontaneous pneumothorax complicating cavitary tuberculosis.  J Thorac Cardiovasc Surg. 1962;  43 561-573
    PubMedGoogle Scholar
  • 36 Korom S, Canyurt H, Missbach A et al.. Catamenial pneumothorax revisited: clinical approach and systematic review of the literature.  J Thorac Cardiovasc Surg. 2004;  128 502-508
    CrossrefPubMedGoogle Scholar
  • 37 Marshall M B, Ahmed Z, Kucharczuk J C, Kaiser L R, Shrager J B. Catamenial pneumothorax: optimal hormonal and surgical management.  Eur J Cardiothorac Surg. 2005;  27 662-666
    CrossrefPubMedGoogle Scholar
  • 38 Peikert T, Gillespie D J, Cassivi S D. Catamenial pneumothorax.  Mayo Clin Proc. 2005;  80 677-680
    CrossrefPubMedGoogle Scholar
  • 39 Velasco Osés A, Hilario Rodriguez E, Santamaría García J L, Aramendi Sanchez T, Coma Corral M J, Pérez Serrano L. Catamenial pneumothorax with pleural endometriosis and hemoptysis.  Diagn Gynecol Obstet. 1982;  4 295-299
    PubMedGoogle Scholar
  • 40 Kradin R L, Mark E J. Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach.  Semin Diagn Pathol. 2006;  23 4-14
    CrossrefPubMedGoogle Scholar
  • 41 Cagle P T, Churg A. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.  Arch Pathol Lab Med. 2005;  129 1421-1427
    PubMedGoogle Scholar
  • 42 Lee S F, Lawrence D, Booth H, Morris-Jones S, Macrae B, Zumla A. Thoracic empyema: current opinions in medical and surgical management.  Curr Opin Pulm Med. 2010;  16 194-200
    PubMedGoogle Scholar
  • 43 Harley R A. Pathology of pleural infections.  Semin Respir Infect. 1988;  3 291-297
    PubMedGoogle Scholar
  • 44 Hughes C E, Van Scoy R E. Antibiotic therapy of pleural empyema.  Semin Respir Infect. 1991;  6 94-102
    PubMedGoogle Scholar
  • 45 Magovern C J, Rusch V W. Parapneumonic and post-traumatic pleural space infections.  Chest Surg Clin N Am. 1994;  4 561-582
    PubMedGoogle Scholar
  • 46 Bender J M, Ampofo K, Sheng X, Pavia A T, Cannon-Albright L, Byington C L. Parapneumonic empyema deaths during past century, Utah.  Emerg Infect Dis. 2009;  15 44-48
    CrossrefPubMedGoogle Scholar
  • 47 Chalmers J D, Singanayagam A, Murray M P, Scally C, Fawzi A, Hill A T. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.  Thorax. 2009;  64 592-597
    CrossrefPubMedGoogle Scholar
  • 48 Krasnik M, Storm H K, Frimodt-Møller N. Pleural empyema.  [in Danish] Ugeskr Laeger. 1996;  158(15) 2109-2112
    PubMedGoogle Scholar
  • 49 Antony V B, Mohammed K A. Pathophysiology of pleural space infections.  Semin Respir Infect. 1999;  14 9-17
    PubMedGoogle Scholar
  • 50 Strange C, Sahn S A. Management of parapneumonic pleural effusions and empyema.  Infect Dis Clin North Am. 1991;  5 539-559
    PubMedGoogle Scholar
  • 51 Bartlett J G. Bacterial infections of the pleural space.  Semin Respir Infect. 1988;  3 308-321
    PubMedGoogle Scholar
  • 52 Everts R J, Reller L B. Pleural space infections: microbiology and antimicrobial therapy.  Semin Respir Infect. 1999;  14 18-30
    PubMedGoogle Scholar
  • 53 Bartlett J G. Anaerobic bacterial infections of the lung and pleural space.  Clin Infect Dis. 1993;  16(Suppl 4) S248-S255
    CrossrefPubMedGoogle Scholar
  • 54 Abrams W B, Small M J. Current concepts of tuberculous pleurisy with effusion as derived from pleural biopsy studies.  Dis Chest. 1960;  38 60-65
    PubMedGoogle Scholar
  • 55 Ibrahim W H, Ghadban W, Khinji A et al.. Does pleural tuberculosis disease pattern differ among developed and developing countries.  Respir Med. 2005;  99 1038-1045
    CrossrefPubMedGoogle Scholar
  • 56 Kim H J, Lee H J, Kwon S Y et al.. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis.  Chest. 2006;  129 1253-1258
    CrossrefPubMedGoogle Scholar
  • 57 George R B, Penn R L, Kinasewitz G T. Mycobacterial, fungal, actinomycotic, and nocardial infections of the pleura.  Clin Chest Med. 1985;  6 63-75
    PubMedGoogle Scholar
  • 58 Lambert R S, George R B. Fungal diseases of the pleura: clinical manifestations, diagnosis, and treatment.  Semin Respir Infect. 1988;  3 343-351
    PubMedGoogle Scholar
  • 59 Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka S. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.  Transplantation. 2009;  88 380-385
    CrossrefPubMedGoogle Scholar
  • 60 Kolditz M, Halank M, Bandt D, Spornraft-Ragaller P, Höffken G. Early recurrence of Pneumocystis jiroveci pneumonia in two HIV-infected patients: linking infection relapse and immune reconstitution syndrome.  Respirology. 2009;  14 910-912
    CrossrefPubMedGoogle Scholar
  • 61 Catanzaro A. Coccidioidomycosis.  Semin Respir Crit Care Med. 2004;  25 123-128
    Article in Thieme ConnectPubMedGoogle Scholar
  • 62 Cano M V, Hajjeh R A. The epidemiology of histoplasmosis: a review.  Semin Respir Infect. 2001;  16 109-118
    PubMedGoogle Scholar
  • 63 Retallack D M, Woods J P. Molecular epidemiology, pathogenesis, and genetics of the dimorphic fungus Histoplasma capsulatum .  Microbes Infect. 1999;  1 817-825
    CrossrefPubMedGoogle Scholar
  • 64 Loulergue P, Mir O. Pleural empyema secondary to amebic liver abscess.  Int J Infect Dis. 2009;  13 e135-e136
    CrossrefPubMedGoogle Scholar
  • 65 Mayo F, Baier H. Cysticercotic cyst involving the pleura: an unusual case of an abnormal chest roentgenogram.  Arch Intern Med. 1979;  139 115-116
    CrossrefPubMedGoogle Scholar
  • 66 Im J G, Whang H Y, Kim W S, Han M C, Shim Y S, Cho S Y. Pleuropulmonary paragonimiasis: radiologic findings in 71 patients.  AJR Am J Roentgenol. 1992;  159 39-43
    PubMedGoogle Scholar
  • 67 Roberts P P. Parasitic infections of the pleural space.  Semin Respir Infect. 1988;  3 362-382
    PubMedGoogle Scholar
  • 68 Williams T, Gostelow B, Woods D, Spyt T. Apical pleural mass developing following talc pleurodesis.  Respir Med. 1998;  92 358-359
    CrossrefPubMedGoogle Scholar
  • 69 Soskel N T, Sharma O P. Pleural involvement in sarcoidosis.  Curr Opin Pulm Med. 2000;  6 455-468
    CrossrefPubMedGoogle Scholar
  • 70 McDonnell T J, Crouch E C, Gonzalez J G. Reactive eosinophilic pleuritis: a sequela of pneumothorax in pulmonary eosinophilic granuloma.  Am J Clin Pathol. 1989;  91 107-111
    PubMedGoogle Scholar
  • 71 Leslie K O, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases.  Semin Respir Crit Care Med. 2007;  28 369-378
    Article in Thieme ConnectPubMedGoogle Scholar
  • 72 van Laar J M, Stolk J, Tyndall A. Scleroderma lung: pathogenesis, evaluation and current therapy.  Drugs. 2007;  67 985-996
    CrossrefPubMedGoogle Scholar
  • 73 Sahn S A. Immunologic diseases of the pleura.  Clin Chest Med. 1985;  6 83-102
    PubMedGoogle Scholar
  • 74 Antony V B. Drug-induced pleural disease.  Clin Chest Med. 1998;  19 331-340
    CrossrefPubMedGoogle Scholar
  • 75 Huggins J T, Sahn S A. Drug-induced pleural disease.  Clin Chest Med. 2004;  25 141-153
    CrossrefPubMedGoogle Scholar
  • 76 Morelock S Y, Sahn S A. Drugs and the pleura.  Chest. 1999;  116 212-221
    CrossrefPubMedGoogle Scholar
  • 77 Huggins J T, Sahn S A. Causes and management of pleural fibrosis.  Respirology. 2004;  9 441-447
    CrossrefPubMedGoogle Scholar
  • 78 Mutsaers S E, Prele C M, Brody A R, Idell S. Pathogenesis of pleural fibrosis.  Respirology. 2004;  9 428-440
    CrossrefPubMedGoogle Scholar
  • 79 Mutsaers S E, Kalomenidis I, Wilson N A, Lee Y C. Growth factors in pleural fibrosis.  Curr Opin Pulm Med. 2006;  12 251-258
    CrossrefPubMedGoogle Scholar
  • 80 Jantz M A, Antony V B. Pleural fibrosis.  Clin Chest Med. 2006;  27 181-191
    CrossrefPubMedGoogle Scholar
  • 81 Miles S E, Sandrini A, Johnson A R, Yates D H. Clinical consequences of asbestos-related diffuse pleural thickening: a review.  J Occup Med Toxicol. 2008;  3 20
    CrossrefPubMedGoogle Scholar
  • 82 Clarke C C, Mowat F S, Kelsh M A, Roberts M A. Pleural plaques: a review of diagnostic issues and possible nonasbestos factors.  Arch Environ Occup Health. 2006;  61 183-192
    CrossrefPubMedGoogle Scholar
  • 83 Wain S L, Roggli V L, Foster Jr W L. Parietal pleural plaques, asbestos bodies, and neoplasia: a clinical, pathologic, and roentgenographic correlation of 25 consecutive cases.  Chest. 1984;  86 707-713
    CrossrefPubMedGoogle Scholar
  • 84 Donath J, Miller A. Restrictive chest wall disorders.  Semin Respir Crit Care Med. 2009;  30 275-292
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Hillerdal G. Non-malignant asbestos pleural disease.  Thorax. 1981;  36 669-675
    CrossrefPubMedGoogle Scholar
  • 86 Stephens M, Gibbs A R, Pooley F D, Wagner J C. Asbestos induced diffuse pleural fibrosis: pathology and mineralogy.  Thorax. 1987;  42 583-588
    CrossrefPubMedGoogle Scholar
  • 87 Mintzer R A, Cugell D W. The association of asbestos-induced pleural disease and rounded atelectasis.  Chest. 1982;  81 457-460
    CrossrefPubMedGoogle Scholar
  • 88 Cugell D W, Kamp D W. Asbestos and the pleura: a review.  Chest. 2004;  125 1103-1117
    CrossrefPubMedGoogle Scholar
  • 89 Remy-Jardin M, Sobaszek A, Duhamel A, Mastora I, Zanetti C, Remy J. Asbestos-related pleuropulmonary diseases: evaluation with low-dose four-detector row spiral CT.  Radiology. 2004;  233 182-190
    CrossrefPubMedGoogle Scholar
  • 90 Arakawa H, Honma K, Saito Y et al.. Pleural disease in silicosis: pleural thickening, effusion, and invagination.  Radiology. 2005;  236 685-693
    CrossrefPubMedGoogle Scholar
  • 91 Mazziotti S, Gaeta M, Costa C et al.. Computed tomography features of liparitosis: a pneumoconiosis due to amorphous silica.  Eur Respir J. 2004;  23 208-213
    CrossrefPubMedGoogle Scholar
  • 92 Zeren E H, Colby T V, Roggli V L. Silica-induced pleural disease: an unusual case mimicking malignant mesothelioma.  Chest. 1997;  112 1436-1438
    CrossrefPubMedGoogle Scholar
  • 93 Young Jr R C, Rachal R E, Carr P G, Press H C. Patterns of coal workers' pneumoconiosis in Appalachian former coal miners.  J Natl Med Assoc. 1992;  84 41-48
    PubMedGoogle Scholar
  • 94 Chapman S J, Cookson W O, Musk A W, Lee Y C. Benign asbestos pleural diseases.  Curr Opin Pulm Med. 2003;  9 266-271
    CrossrefPubMedGoogle Scholar
  • 95 Batra P, Brown K, Hayashi K, Mori M. Rounded atelectasis.  J Thorac Imaging. 1996;  11 187-197
    PubMedGoogle Scholar
  • 96 Szydlowski G W, Cohn H E, Steiner R M, Edie R N. Rounded atelectasis: a pulmonary pseudotumor.  Ann Thorac Surg. 1992;  53 817-821
    CrossrefPubMedGoogle Scholar
  • 97 Jaurand M C, Fleury-Feith J. Pathogenesis of malignant pleural mesothelioma.  Respirology. 2005;  10 2-8
    CrossrefPubMedGoogle Scholar
  • 98 Marchevsky A M, Wick M R. Current controversies regarding the role of asbestos exposure in the causation of malignant mesothelioma: the need for an evidence-based approach to develop medicolegal guidelines.  Ann Diagn Pathol. 2003;  7 321-332
    CrossrefPubMedGoogle Scholar
  • 99 Donaldson K, Murphy F A, Duffin R, Poland C A. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma.  Part Fibre Toxicol. 2010;  7 5
    CrossrefPubMedGoogle Scholar
  • 100 Heintz N H, Janssen-Heininger Y M, Mossman B T. Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways.  Am J Respir Cell Mol Biol. 2010;  42 133-139
    CrossrefPubMedGoogle Scholar
  • 101 Bourdès V, Boffetta P, Pisani P. Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis.  Eur J Epidemiol. 2000;  16 411-417
    CrossrefPubMedGoogle Scholar
  • 102 Borow M, Conston A, Livornese L L, Schalet N. Mesothelioma and its association with asbestosis.  JAMA. 1967;  201 587-591
    CrossrefPubMedGoogle Scholar
  • 103 Borow M, Conston A, Livornese L, Schalet N. Mesothelioma following exposure to asbestos: a review of 72 cases.  Chest. 1973;  64 641-646
    CrossrefPubMedGoogle Scholar
  • 104 Connelly R R, Spirtas R, Myers M H, Percy C L, Fraumeni Jr J F. Demographic patterns for mesothelioma in the United States.  J Natl Cancer Inst. 1987;  78 1053-1060
    PubMedGoogle Scholar
  • 105 Nishimura S L, Broaddus V C. Asbestos-induced pleural disease.  Clin Chest Med. 1998;  19 311-329
    CrossrefPubMedGoogle Scholar
  • 106 Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic.  Br J Cancer. 1999;  79 666-672
    CrossrefPubMedGoogle Scholar
  • 107 Peto J, Hodgson J T, Matthews F E, Jones J R. Continuing increase in mesothelioma mortality in Britain.  Lancet. 1995;  345 535-539
    CrossrefPubMedGoogle Scholar
  • 108 Treasure T, Waller D, Swift S, Peto J. Radical surgery for mesothelioma.  BMJ. 2004;  328 237-238
    CrossrefPubMedGoogle Scholar
  • 109 Kaufman A J, Pass H I. Current concepts in malignant pleural mesothelioma.  Expert Rev Anticancer Ther. 2008;  8 293-303
    CrossrefPubMedGoogle Scholar
  • 110 Lanphear B P, Buncher C R. Latent period for malignant mesothelioma of occupational origin.  J Occup Med. 1992;  34 718-721
    PubMedGoogle Scholar
  • 111 Ohar J, Sterling D A, Bleecker E, Donohue J. Changing patterns in asbestos-induced lung disease.  Chest. 2004;  125 744-753
    CrossrefPubMedGoogle Scholar
  • 112 Legha S S, Muggia F M. Pleural mesothelioma: clinical features and therapeutic implications.  Ann Intern Med. 1977;  87 613-621
    PubMedGoogle Scholar
  • 113 Brenner J, Sordillo P P, Magill G B, Golbey R B. Malignant mesothelioma of the pleura: review of 123 patients.  Cancer. 1982;  49 2431-2435
    CrossrefPubMedGoogle Scholar
  • 114 Adams V I, Unni K K, Muhm J R, Jett J R, Ilstrup D M, Bernatz P E. Diffuse malignant mesothelioma of pleura: diagnosis and survival in 92 cases.  Cancer. 1986;  58 1540-1551
    CrossrefPubMedGoogle Scholar
  • 115 Elmes P C, Simpson J C. The clinical aspects of mesothelioma.  Q J Med. 1976;  45 427-449
    PubMedGoogle Scholar
  • 116 Crotty T B, Myers J L, Katzenstein A L, Tazelaar H D, Swensen S J, Churg A. Localized malignant mesothelioma: a clinicopathologic and flow cytometric study.  Am J Surg Pathol. 1994;  18 357-363
    CrossrefPubMedGoogle Scholar
  • 117 Allen T C, Cagle P T, Churg A M et al.. Localized malignant mesothelioma.  Am J Surg Pathol. 2005;  29 866-873
    CrossrefPubMedGoogle Scholar
  • 118 van Ruth S, Baas P, Zoetmulder F A. Surgical treatment of malignant pleural mesothelioma: a review.  Chest. 2003;  123 551-561
    CrossrefPubMedGoogle Scholar
  • 119 Butnor K J, Sporn T A, Hammar S P, Roggli V L. Well-differentiated papillary mesothelioma.  Am J Surg Pathol. 2001;  25 1304-1309
    CrossrefPubMedGoogle Scholar
  • 120 Hammar S P, Bolen J W. Sarcomatoid pleural mesothelioma.  Ultrastruct Pathol. 1985;  9 337-343
    CrossrefPubMedGoogle Scholar
  • 121 Klima M, Bossart M I. Sarcomatous type of malignant mesothelioma.  Ultrastruct Pathol. 1983;  4 349-358
    CrossrefPubMedGoogle Scholar
  • 122 Mangano W E, Cagle P T, Churg A, Vollmer R T, Roggli V L. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.  Am J Clin Pathol. 1998;  110 191-199
    PubMedGoogle Scholar
  • 123 Attanoos R L, Gibbs A R. Pathology of malignant mesothelioma.  Histopathology. 1997;  30 403-418
    CrossrefPubMedGoogle Scholar
  • 124 Roggli V L, Kolbeck J, Sanfilippo F, Shelburne J D. Pathology of human mesothelioma: etiologic and diagnostic considerations.  Pathol Annu. 1987;  22(Pt 2) 91-131
    PubMedGoogle Scholar
  • 125 Van Marck E. Pathology of malignant mesothelioma.  Lung Cancer. 2004;  45(Suppl 1) S35-S36
    CrossrefPubMedGoogle Scholar
  • 126 Corson J M. Pathology of mesothelioma.  Thorac Surg Clin. 2004;  14 447-460
    CrossrefPubMedGoogle Scholar
  • 127 Mark E J, Kradin R L. Pathological recognition of diffuse malignant mesothelioma of the pleura: the significance of the historical perspective as regards this signal tumor.  Semin Diagn Pathol. 2006;  23 25-34
    CrossrefPubMedGoogle Scholar
  • 128 O'Byrne K J, Edwards J G, Waller D A. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma.  Lung Cancer. 2004;  45(Suppl 1) S45-S48
    PubMedGoogle Scholar
  • 129 Churg A, Colby T V, Cagle P et al.. The separation of benign and malignant mesothelial proliferations.  Am J Surg Pathol. 2000;  24 1183-1200
    CrossrefPubMedGoogle Scholar
  • 130 Cury P M, Butcher D N, Corrin B, Nicholson A G. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.  J Pathol. 1999;  189 251-257
    CrossrefPubMedGoogle Scholar
  • 131 Kutty C P, Remeniuk E, Varkey B. Malignant-appearing cells in pleural effusion due to pancreatitis: case report and literature review.  Acta Cytol. 1981;  25 412-416
    PubMedGoogle Scholar
  • 132 Henderson D W, Shilkin K B, Whitaker D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review.  Am J Clin Pathol. 1998;  110 397-404
    PubMedGoogle Scholar
  • 133 Bono F, Lombardi M. Prominent in situ component in a pleural malignant mesothelioma.  Int J Surg Pathol. 2010;  Jul 18. [Epub ahead of print]
    PubMedGoogle Scholar
  • 134 Kaplan M A, Tazelaar H D, Hayashi T, Schroer K R, Travis W D. Adenomatoid tumors of the pleura.  Am J Surg Pathol. 1996;  20 1219-1223
    CrossrefPubMedGoogle Scholar
  • 135 Stout A P, Murray M R. Localized pleural mesothelioma.  Arch Pathol (Chic). 1942;  34 951-962
    PubMedGoogle Scholar
  • 136 Briselli M, Mark E J, Dickersin G R. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature.  Cancer. 1981;  47 2678-2689
    CrossrefPubMedGoogle Scholar
  • 137 Lu C, Ji Y, Shan F, Guo W, Ding J, Ge D. Solitary fibrous tumor of the pleura: an analysis of 13 cases.  World J Surg. 2008;  32 1663-1668
    CrossrefPubMedGoogle Scholar
  • 138 Saha S P. Solitary fibrous tumor of the pleura.  Int Surg. 2007;  92 351-354
    PubMedGoogle Scholar
  • 139 Lee S C, Tzao C, Ou S M, Hsu H H, Yu C P, Cheng Y L. Solitary fibrous tumors of the pleura: clinical, radiological, surgical and pathological evaluation.  Eur J Surg Oncol. 2005;  31 84-87
    CrossrefPubMedGoogle Scholar
  • 140 Ordóñez N G. Localized (solitary) fibrous tumor of the pleura.  Adv Anat Pathol. 2000;  7 327-340
    CrossrefPubMedGoogle Scholar
  • 141 Moran C A, Suster S, Koss M N. The spectrum of histologic growth patterns in benign and malignant fibrous tumors of the pleura.  Semin Diagn Pathol. 1992;  9 169-180
    PubMedGoogle Scholar
  • 142 England D M, Hochholzer L, McCarthy M J. Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases.  Am J Surg Pathol. 1989;  13 640-658
    Google Scholar
  • 143 Flint A, Weiss S W. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma.  Hum Pathol. 1995;  26 428-431
    CrossrefPubMedGoogle Scholar
  • 144 Butnor K J, Burchette J L, Sporn T A, Hammar S P, Roggli V L. The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature.  Arch Pathol Lab Med. 2004;  128 538-543
    PubMedGoogle Scholar
  • 145 Gladish G W, Sabloff B M, Munden R F, Truong M T, Erasmus J J, Chasen M H. Primary thoracic sarcomas.  Radiographics. 2002;  22 621-637
    PubMedGoogle Scholar
  • 146 Ognibene F P, Shelhamer J H. Kaposi's sarcoma.  Clin Chest Med. 1988;  9 459-465
    PubMedGoogle Scholar
  • 147 Floris C, Sulis M L, Bernascani M, Turno R, Tedde A, Sulis E. Pneumothorax in pleuropulmonary Kaposi's sarcoma related to acquired immunodeficiency syndrome.  Am J Med. 1989;  87 123-124
    CrossrefPubMedGoogle Scholar
  • 148 O'Brien R F, Cohn D L. Serosanguineous pleural effusions in AIDS-associated Kaposi's sarcoma.  Chest. 1989;  96 460-466
    CrossrefPubMedGoogle Scholar
  • 149 Pandya K, Lal C, Tuchschmidt J, Boylen C T, Sharma O P. Bilateral chylothorax with pulmonary Kaposi's sarcoma.  Chest. 1988;  94 1316-1317
    PubMedGoogle Scholar
  • 150 Yousem S A. Angiosarcoma presenting in the lung.  Arch Pathol Lab Med. 1986;  110 112-115
    PubMedGoogle Scholar
  • 151 Bocklage T, Leslie K, Yousem S, Colby T. Extracutaneous angiosarcomas metastatic to the lungs: clinical and pathologic features of twenty-one cases.  Mod Pathol. 2001;  14 1216-1225
    CrossrefPubMedGoogle Scholar
  • 152 Lin B T, Colby T, Gown A M et al.. Malignant vascular tumors of the serous membranes mimicking mesothelioma: a report of 14 cases.  Am J Surg Pathol. 1996;  20 1431-1439
    CrossrefPubMedGoogle Scholar
  • 153 Falconieri G, Bussani R, Mirra M, Zanella M. Pseudomesotheliomatous angiosarcoma: a pleuropulmonary lesion simulating malignant pleural mesothelioma.  Histopathology. 1997;  30 419-424
    CrossrefPubMedGoogle Scholar
  • 154 Engleman P, Liebow A A, Gmelich J, Friedman P J. Pulmonary hyalinizing granuloma.  Am Rev Respir Dis. 1977;  115 997-1008
    PubMedGoogle Scholar
  • 155 Yousem S A, Hochholzer L. Pulmonary hyalinizing granuloma.  Am J Clin Pathol. 1987;  87 1-6
    PubMedGoogle Scholar
  • 156 Satti M B, Batouk A A, Abdelaziz M M, Ahmad M F, Abdelaal M A. Pulmonary hyalinizing granuloma: bilateral pulmonary nodules associated with chronic idiopathic thrombocytopenic purpura.  Saudi Med J. 2005;  26 1459-1463
    PubMedGoogle Scholar
  • 157 Pinkard N B, Wilson R W, Lawless N et al.. Calcifying fibrous pseudotumor of pleura: a report of three cases of a newly described entity involving the pleura.  Am J Clin Pathol. 1996;  105 189-194
    CrossrefPubMedGoogle Scholar
  • 158 Jiang K, Nie J, Wang J, Li J. Multiple calcifying fibrous pseudotumor of the bilateral pleura.  Jpn J Clin Oncol. 2010;  Jul 9. [Epub ahead of print]
    Google Scholar
  • 159 Shibata K, Yuki D, Sakata K. Multiple calcifying fibrous pseudotumors disseminated in the pleura.  Ann Thorac Surg. 2008;  85 e3-e5
    CrossrefPubMedGoogle Scholar
  • 160 Hainaut P, Lesage V, Weynand B, Coche E, Noirhomme P. Calcifying fibrous pseudotumor (CFPT): a patient presenting with multiple pleural lesions.  Acta Clin Belg. 1999;  54 162-164
    PubMedGoogle Scholar
  • 161 Soyer T, Ciftci A O, Güçer S, Orhan D, Senocak M E. Calcifying fibrous pseudotumor of lung: a previously unreported entity.  J Pediatr Surg. 2004;  39 1729-1730
    CrossrefPubMedGoogle Scholar
  • 162 Sahn S A. Malignancy metastatic to the pleura.  Clin Chest Med. 1998;  19 351-361
    CrossrefPubMedGoogle Scholar
  • 163 Matthay R A, Coppage L, Shaw C, Filderman A E. Malignancies metastatic to the pleura.  Invest Radiol. 1990;  25 601-619
    CrossrefPubMedGoogle Scholar
  • 164 Husain A N, Colby T V, Ordóñez N G et al.. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.  Arch Pathol Lab Med. 2009;  133 1317-1331
    PubMedGoogle Scholar
  • 165 Marchevsky A M, Wick M R. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma.  Appl Immunohistochem Mol Morphol. 2007;  15 140-144
    PubMedGoogle Scholar
  • 166 Attanoos R L, Gibbs A R. “Pseudomesotheliomatous” carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff.  Histopathology. 2003;  43 444-452
    CrossrefPubMedGoogle Scholar
  • 167 Koss L G. Benign and malignant mesothelial proliferations.  Am J Surg Pathol. 2001;  25 548-549
    CrossrefPubMedGoogle Scholar
  • 168 Molinie V, Pouchot J, Navratil E, Aubert F, Vinceneux P, Barge J. Primary Epstein-Barr virus-related non-Hodgkin's lymphoma of the pleural cavity following long-standing tuberculous empyema.  Arch Pathol Lab Med. 1996;  120 288-291
    PubMedGoogle Scholar
  • 169 Hengge U R, Ruzicka T, Tyring S K et al.. Update on Kaposi's sarcoma and other HHV8 associated diseases: II: Pathogenesis, Castleman's disease, and pleural effusion lymphoma.  Lancet Infect Dis. 2002;  2 344-352
    CrossrefPubMedGoogle Scholar
  • 170 Sunil M, Reid E, Lechowicz M J. Update on HHV-8-associated malignancies.  Curr Infect Dis Rep. 2010;  12 147-154
    CrossrefPubMedGoogle Scholar
  • 171 Carbone A, Cesarman E, Spina M, Gloghini A, Schulz T F. HIV-associated lymphomas and gamma-herpesviruses.  Blood. 2009;  113 1213-1224
    CrossrefPubMedGoogle Scholar
  • 172 Savage K J. Rare B-cell lymphomas: primary mediastinal, intravascular, and primary effusion lymphoma.  Cancer Treat Res. 2008;  142 243-264
    PubMedGoogle Scholar
  • 173 Vu H N, Jenkins F W, Swerdlow S H, Locker J, Lotze M T. Pleural effusion as the presentation for primary effusion lymphoma.  Surgery. 1998;  123 589-591
    CrossrefPubMedGoogle Scholar
  • 174 Bhojawala J, Heller D S, Cracchiolo B, Sama J. Endometriosis presenting as bloody pleural effusion and ascites-report of a case and review of the literature.  Arch Gynecol Obstet. 2000;  264 39-41
    CrossrefPubMedGoogle Scholar
  • 175 Channabasavaiah A D, Joseph J V. Thoracic endometriosis: revisiting the association between clinical presentation and thoracic pathology based on thoracoscopic findings in 110 patients.  Medicine (Baltimore). 2010;  89 183-188
    CrossrefPubMedGoogle Scholar
  • 176 Charles D. Endometriosis and hemorrhagic pleural effusion.  Obstet Gynecol. 1957;  10 309-312
    PubMedGoogle Scholar
  • 177 Dhanaworavibul K, Hanprasertpong J, Cheewadhanaraks S, Buhachat R. Bilateral pleural endometriosis.  J Obstet Gynaecol Res. 2006;  32 86-89
    CrossrefPubMedGoogle Scholar
  • 178 El Ghazal R, Fabian T, Ahmed Z A, Moritz E D. Thoracic endometriosis: an unusual cause of hemothorax.  Conn Med. 2009;  73 453-456
    PubMedGoogle Scholar
  • 179 Johnson M M. Catamenial pneumothorax and other thoracic manifestations of endometriosis.  Clin Chest Med. 2004;  25 311-319
    CrossrefPubMedGoogle Scholar
  • 180 McKeen S, Dharsono F. Thoracic splenosis: diagnosis of a case based on history and computerized tomography findings.  Australas Radiol. 2007;  51(Suppl) B246-B249
    CrossrefPubMedGoogle Scholar
  • 181 Yammine J N, Yatim A, Barbari A. Radionuclide imaging in thoracic splenosis and a review of the literature.  Clin Nucl Med. 2003;  28 121-123
    CrossrefPubMedGoogle Scholar
  • 182 Ruffini E, Asioli S, Filosso P L et al.. Intrathoracic splenosis: a case report and an update of invasive and noninvasive diagnostic techniques.  J Thorac Cardiovasc Surg. 2007;  134 1594-1595
    CrossrefPubMedGoogle Scholar
  • 183 Papakonstantinou C, Christoforidis E, Vasiliadis K, Kanellos I, Zarogoulidis K. Thoracic splenosis twenty-nine years after traumatic splenectomy mimicking intrathoracic neoplasm.  Eur Surg Res. 2005;  37 76-78
    CrossrefPubMedGoogle Scholar
  • 184 Kim K, Choi H J, Kim Y M, Kwon W J, Lee W C, Suh J H. Thoracic splenosis: a case report and the importance of clinical history.  J Korean Med Sci. 2010;  25 299-303
    CrossrefPubMedGoogle Scholar
  • 185 Khan A M, Manzoor K, Gordon D, Berman A. Thoracic splenosis: a diagnosis by history and imaging.  Respirology. 2008;  13 481-483
    CrossrefPubMedGoogle Scholar
  • 186 Gaines J J, Crosby J H, Vinayak Kamath M. Diagnosis of thoracic splenosis by tru-cut needle biopsy.  Am Rev Respir Dis. 1986;  133 1199-1201
    PubMedGoogle Scholar
  • 187 Looi L M. The pattern of amyloid deposition in the lung.  Malays J Pathol. 1999;  21 29-35
    PubMedGoogle Scholar
  • 188 Knapp M J, Roggli V L, Kim J, Moore J O, Shelburne J D. Pleural amyloidosis.  Arch Pathol Lab Med. 1988;  112 57-60
    PubMedGoogle Scholar
  • 189 Granel B, Serratrice J, Disdier P, Weiller P J, Astoul P. Systemic amyloidosis with pleural involvement.  Am J Med. 2003;  115 742-743
    CrossrefPubMedGoogle Scholar
  • 190 Graham D R, Ahmad D. Amyloidosis with pleural involvement.  Eur Respir J. 1988;  1 571-572
    PubMedGoogle Scholar
  • 191 Bridges K G, Welch G, Silver M, Schinco M A, Esposito B. CT detection of occult pneumothorax in multiple trauma patients.  J Emerg Med. 1993;  11 179-186
    CrossrefPubMedGoogle Scholar
  • 192 Hill S L, Edmisten T, Holtzman G, Wright A. The occult pneumothorax: an increasing diagnostic entity in trauma.  Am Surg. 1999;  65 254-258
    PubMedGoogle Scholar
  • 193 Henderson S O, Shoenberger J M. Anterior pneumothorax and a negative chest X-ray in trauma.  J Emerg Med. 2004;  26 231-232
    CrossrefPubMedGoogle Scholar
  • 194 Misthos P, Kakaris S, Sepsas E, Athanassiadi K, Skottis I. A prospective analysis of occult pneumothorax, delayed pneumothorax and delayed hemothorax after minor blunt thoracic trauma.  Eur J Cardiothorac Surg. 2004;  25 859-864
    CrossrefPubMedGoogle Scholar
  • 195 Peguero F A, Netzman A. Bullous emphysema and pneumothorax.  J Med Soc N J. 1985;  82 743-745
    PubMedGoogle Scholar
  • 196 DeVries W C, Wolfe W G. The management of spontaneous pneumothorax and bullous emphysema.  Surg Clin North Am. 1980;  60 851-866
    PubMedGoogle Scholar
  • 197 Beers M F, Sohn M, Swartz M. Recurrent pneumothorax in AIDS patients with Pneumocystis pneumonia: a clinicopathologic report of three cases and review of the literature.  Chest. 1990;  98 266-270
    CrossrefPubMedGoogle Scholar
  • 198 Pastores S M, Garay S M, Naidich D P, Rom W N. Review: pneumothorax in patients with AIDS-related Pneumocystis carinii pneumonia.  Am J Med Sci. 1996;  312 229-234
    CrossrefPubMedGoogle Scholar
  • 199 Tumbarello M, Tacconelli E, Pirronti T, Cauda R, Ortona L. Pneumothorax in HIV-infected patients: role of Pneumocystis carinii pneumonia and pulmonary tuberculosis.  Eur Respir J. 1997;  10 1332-1335
    CrossrefPubMedGoogle Scholar
  • 200 Mendez J L, Nadrous H F, Vassallo R, Decker P A, Ryu J H. Pneumothorax in pulmonary Langerhans cell histiocytosis.  Chest. 2004;  125 1028-1032
    CrossrefPubMedGoogle Scholar
  • 201 Bearz A, Rupolo M, Canzonieri V et al.. Lymphangioleiomyomatosis: a case report and review of the literature.  Tumori. 2004;  90 528-531
    PubMedGoogle Scholar
  • 202 Flume P A. Pneumothorax in cystic fibrosis.  Chest. 2003;  123 217-221
    CrossrefPubMedGoogle Scholar
  • 203 Noppen M, Baumann M H. Pathogenesis and treatment of primary spontaneous pneumothorax: an overview.  Respiration. 2003;  70 431-438
    CrossrefPubMedGoogle Scholar
  • 204 Sassoon C S, Light R W, O'Hara V S, Moritz T E. Iatrogenic pneumothorax: etiology and morbidity: results of a Department of Veterans Affairs Cooperative Study.  Respiration. 1992;  59 215-220
    CrossrefPubMedGoogle Scholar
  • 205 Despars J A, Sassoon C S, Light R W. Significance of iatrogenic pneumothoraces.  Chest. 1994;  105 1147-1150
    CrossrefPubMedGoogle Scholar
  • 206 Smith P R, Nacht R I. Drug-induced lupus pleuritis mimicking pleural space infection.  Chest. 1992;  101 268-269
    CrossrefPubMedGoogle Scholar
  • 207 Good Jr J T, King T E, Antony V B, Sahn S A. Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies.  Chest. 1983;  84 714-718
    CrossrefPubMedGoogle Scholar
  • 208 Graham W R. Rheumatoid pleuritis.  South Med J. 1990;  83 973-975
    CrossrefPubMedGoogle Scholar
  • 209 Owens M W, Milligan S A. Pleuritis and pleural effusions.  Curr Opin Pulm Med. 1995;  1 318-323
    PubMedGoogle Scholar
  • 210 Chou C W, Chang S C. Pleuritis as a presenting manifestation of rheumatoid arthritis: diagnostic clues in pleural fluid cytology.  Am J Med Sci. 2002;  323 158-161
    CrossrefPubMedGoogle Scholar
  • 211 Morelock S Y, Sahn S A. Drugs and the pleura.  Chest. 1999;  116 212-221
    CrossrefPubMedGoogle Scholar
  • 212 Mandal A K, Thadepalli H, Mandal A K, Chettipalli U. Posttraumatic empyema thoracis: a 24-year experience at a major trauma center.  J Trauma. 1997;  43 764-771
    CrossrefPubMedGoogle Scholar
  • 213 Kaye M D. Pleuropulmonary complications of pancreatitis.  Thorax. 1968;  23 297-306
    CrossrefPubMedGoogle Scholar
  • 214 Saugier B, Emonot A, Berard P, Faguer P, Galy P. Pleuresies in chronic pancreatitis and in pancreatic pseudocysts: a study apropos of 20 cases.  [in French] Poumon Coeur. 1976;  32 233-240
    PubMedGoogle Scholar
  • 215 Fentanes de Torres E, Guevara E. Pleuritis by radiation: reports of two cases.  Acta Cytol. 1981;  25 427-429
    PubMedGoogle Scholar
  • 216 Shrivastava R, Venkatesh S, Pavlovich B B, Bharadwaj J, Vaz A. Immunological analysis of pleural fluid in post-cardiac injury syndrome.  Postgrad Med J. 2002;  78 362-363
    CrossrefPubMedGoogle Scholar
  • 217 Vallyathan N V, Green F H, Craighead J E. Recent advances in the study of mineral pneumoconiosis.  Pathol Annu. 1980;  15(Pt 2) 77-104
    PubMedGoogle Scholar
  • 218 Maher J F. Uremic pleuritis.  Am J Kidney Dis. 1987;  10 19-22
    PubMedGoogle Scholar
  • 219 Yoshii C, Morita S, Tokunaga M et al.. Bilateral massive pleural effusions caused by uremic pleuritis.  Intern Med. 2001;  40 646-649
    CrossrefPubMedGoogle Scholar
  • 220 Hage C A, abdul-Mohammed K, Antony V B. Pathogenesis of pleural infection.  Respirology. 2004;  9 12-15
    CrossrefPubMedGoogle Scholar
  • 221 Oba S, Akuma M. Localized bilateral empyema caused by spontaneous esophageal rupture.  [in Japanese] Rinsho Hoshasen. 1985;  30 395-396
    PubMedGoogle Scholar
  • 222 Sees D W, Obney J A, Tripp H F. Empyema complicating muscle-sparing thoracotomy: the role of wound management.  Am Surg. 2002;  68 390-391
    PubMedGoogle Scholar
  • 223 Irving A D, Turner M A. Pleural empyema in association with renal sepsis.  Br J Surg. 1976;  63 70-72
    CrossrefPubMedGoogle Scholar
  • 224 Clarridge J, Roberts C, Peters J, Musher D. Sepsis and empyema caused by Yersinia enterocolitica .  J Clin Microbiol. 1983;  17 936-938
    PubMedGoogle Scholar
  • 225 Ballantyne K C, Sethia B, Reece I J, Davidson K G. Empyema following intra-abdominal sepsis.  Br J Surg. 1984;  71 723-725
    CrossrefPubMedGoogle Scholar
  • 226 Iscovich A L, Salvucci A A. Streptococcal sepsis and death caused by empyema.  Am J Emerg Med. 1986;  4 28-30
    CrossrefPubMedGoogle Scholar
  • 227 Samelson S L, Ferguson M K. Empyema following percutaneous catheter drainage of upper abdominal abscess.  Chest. 1992;  102 1612-1614
    CrossrefPubMedGoogle Scholar
  • 228 Ellman P, Cudkowicz L, Elwood J S. Widespread serous membrane involvement by rheumatoid nodules.  J Clin Pathol. 1954;  7 239-244
    CrossrefPubMedGoogle Scholar
  • 229 Jurik A G, Graudal H. Pleurisy in rheumatoid arthritis.  Scand J Rheumatol. 1983;  12 75-80
    CrossrefPubMedGoogle Scholar
  • 230 Robinson A C, Power J, Clancy L, Sweeney E. Recurrent pneumothorax in rheumatoid arthritis.  Ir J Med Sci. 1984;  153 437-438
    CrossrefPubMedGoogle Scholar
  • 231 Engel U, Aru A, Francis D. Rheumatoid pleurisy: specificity of cytological findings.  Acta Pathol Microbiol Immunol Scand [A]. 1986;  94 53-56
    PubMedGoogle Scholar
  • 232 Anaya J M, Diethelm L, Ortiz L A et al.. Pulmonary involvement in rheumatoid arthritis.  Semin Arthritis Rheum. 1995;  24 242-254
    CrossrefPubMedGoogle Scholar
  • 233 Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications.  Chest. 1985;  88 129-135
    CrossrefPubMedGoogle Scholar
  • 234 Wang D Y, Chang D B, Kuo S H et al.. Systemic lupus erythematosus presenting as pleural effusion: report of a case.  J Formos Med Assoc. 1995;  94 746-749
    PubMedGoogle Scholar
  • 235 Wang D Y. Diagnosis and management of lupus pleuritis.  Curr Opin Pulm Med. 2002;  8 312-316
    CrossrefPubMedGoogle Scholar
  • 236 Quismorio Jr F P. Pulmonary involvement in primary Sjögren's syndrome.  Curr Opin Pulm Med. 1996;  2 424-428
    CrossrefPubMedGoogle Scholar
  • 237 Kawamata K, Haraoka H, Hirohata S, Hashimoto T, Jenkins R N, Lipsky P E. Pleurisy in primary Sjögren's syndrome: T cell receptor beta-chain variable region gene bias and local autoantibody production in the pleural effusion.  Clin Exp Rheumatol. 1997;  15 193-196
    PubMedGoogle Scholar
  • 238 Weir I H, Müller N L, Chiles C, Godwin J D, Lee S H, Kullnig P. Wegener's granulomatosis: findings from computed tomography of the chest in 10 patients.  Can Assoc Radiol J. 1992;  43 31-34
    PubMedGoogle Scholar
  • 239 Kuhlman J E, Hruban R H, Fishman E K. Wegener granulomatosis: CT features of parenchymal lung disease.  J Comput Assist Tomogr. 1991;  15 948-952
    CrossrefPubMedGoogle Scholar
  • 240 Maguire R, Fauci A S, Doppman J L, Wolff S M. Unusual radiographic features of Wegener's granulomatosis.  AJR Am J Roentgenol. 1978;  130 233-238
    PubMedGoogle Scholar
  • 241 Craighead J E, Mossman B T, Bradley B J. Comparative studies on the cytotoxicity of amphibole and serpentine asbestos.  Environ Health Perspect. 1980;  34 37-46
    CrossrefPubMedGoogle Scholar
  • 242 Hendry N. The geologic occurrences and major uses of asbestos.  Ann NY Acad Sci. 1965;  132 12-21
    CrossrefPubMedGoogle Scholar
  • 243 Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma.  Histopathology. 1997;  31 140-143
    CrossrefPubMedGoogle Scholar
  • 244 Ordóñez N G. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.  Am J Surg Pathol. 1998;  22 1215-1221
    CrossrefPubMedGoogle Scholar
  • 245 Dei Tos A P, Doglioni C. Calretinin: a novel tool for diagnostic immunohistochemistry.  Adv Anat Pathol. 1998;  5 61-66
    CrossrefPubMedGoogle Scholar
  • 246 Ordóñez N G. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.  Mod Pathol. 1998;  11 929-933
    CrossrefPubMedGoogle Scholar
  • 247 Ordóñez N G. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.  Am J Surg Pathol. 2003;  27 1031-1051
    CrossrefPubMedGoogle Scholar
  • 248 Ordóñez N G. The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies.  Am J Surg Pathol. 1997;  21 1399-1408
    CrossrefPubMedGoogle Scholar
  • 249 González-Lois C, Ballestín C, Sotelo M T, López-Ríos F, García-Prats M D, Villena V. Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura.  Histopathology. 2001;  38 528-534
    CrossrefPubMedGoogle Scholar
  • 250 Gümürdülü D, Zeren E H, Cagle P T et al.. Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages.  Pathol Oncol Res. 2002;  8 188-193
    CrossrefPubMedGoogle Scholar
  • 251 Foster M R, Johnson J E, Olson S J, Allred D C. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas.  Arch Pathol Lab Med. 2001;  125 1316-1320
    PubMedGoogle Scholar
  • 252 al-Saffar N, Hasleton P S. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.  Eur Respir J. 1990;  3 997-1001
    PubMedGoogle Scholar
  • 253 Duggan M A, Masters C B, Alexander F. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.  Acta Cytol. 1987;  31 807-814
    PubMedGoogle Scholar
  • 254 Wang N S, Huang S N, Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers.  Cancer. 1979;  44 937-943
    CrossrefPubMedGoogle Scholar
  • 255 Riera J R, Astengo-Osuna C, Longmate J A, Battifora H. The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval.  Am J Surg Pathol. 1997;  21 1409-1419
    CrossrefPubMedGoogle Scholar
  • 256 Khoor A, Whitsett J A, Stahlman M T, Olson S J, Cagle P T. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma.  Hum Pathol. 1999;  30 695-700
    CrossrefPubMedGoogle Scholar
  • 257 Ordóñez N G. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.  Am J Surg Pathol. 2000;  24 598-606
    CrossrefPubMedGoogle Scholar
  • 258 Gaffey M J, Mills S E, Swanson P E, Zarbo R J, Shah A R, Wick M R. Immunoreactivity for BER-EP4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas.  Am J Surg Pathol. 1992;  16 593-599
    CrossrefPubMedGoogle Scholar
  • 259 Ordóñez N G. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma: the M.D. Anderson experience and a critical review of the literature.  Am J Clin Pathol. 1998;  109 85-89
    PubMedGoogle Scholar
  • 260 Ordóñez N G. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.  Hum Pathol. 1998;  29 166-169
    CrossrefPubMedGoogle Scholar
  • 261 Comin C E, Novelli L, Boddi V, Paglierani M, Dini S. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.  Hum Pathol. 2001;  32 529-536
    CrossrefPubMedGoogle Scholar
  • 262 Szpak C A, Johnston W W, Roggli V et al.. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).  Am J Pathol. 1986;  122 252-260
    PubMedGoogle Scholar
  • 263 Warnock M L, Stoloff A, Thor A. Differentiation of adenocarcinoma of the lung from mesothelioma: periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1.  Am J Pathol. 1988;  133 30-38
    PubMedGoogle Scholar
  • 264 Saad R S, Lindner J L, Lin X, Liu Y L, Silverman J F. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.  Diagn Cytopathol. 2006;  34 801-806
    CrossrefPubMedGoogle Scholar

Kevin O LeslieM.D. 

Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona

13400 East Shea Blvd., Scottsdale, AZ 85259

Email: Leslie.Kevin@mayo.edu

      >